My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Gilead Sciences (NQ:GILD)

126.77 -0.41 (-0.32%)

Streaming Delayed Price Updated: 11:12 AM EST, Nov 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gilead Sciences

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

68 69 Next >

Gilead Sciences Announces Fourth Quarter and Full Year 2024 Financial Results

February 11, 2025

From Gilead Sciences, Inc.

Via Business Wire

US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday? ↗

February 11, 2025

U.S.

Via Benzinga

Gilead Sciences Options Trading: A Deep Dive into Market Sentiment ↗

February 10, 2025

Via Benzinga

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today ↗

January 31, 2025

Via Benzinga

Looking At Gilead Sciences's Recent Unusual Options Activity ↗

January 29, 2025

Via Benzinga

US Stock To Likely Open Lower Amid Tariff Tensions: Expert Hints Sans Lower Tariffs It's Hard To See The 'Market Going Up' ↗

February 11, 2025

U.S. stock futures fell on Tuesday after ending higher on Monday a revenue miss from McDonald's Corp and weak ON Semiconductor Corp earnings.

Via Benzinga

Nasdaq Gains 1% As Nvidia, Broadcom Surge: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone ↗

February 11, 2025

The CNN Fear and Greed Index improved to Neutral zone on Monday with the overall market sentiment improving. U.S. stocks closed higher, led by tech gains.

Via Benzinga

Coca-Cola, Marriott International And 3 Stocks To Watch Heading Into Tuesday ↗

February 11, 2025

Via Benzinga

Markets Steady, Positive; Q4 Earnings Keep Rolling ↗

February 10, 2025

Markets were flat but positive in an initial trading day for a new week, basically shrugging off whatever warning signs may have been considered regarding President Trump’s 25% steel tariff headline...

Via Talk Markets

Topics Government Stocks / Equities World Trade

Breaking Down Gilead Sciences: 22 Analysts Share Their Views ↗

January 29, 2025

Via Benzinga

Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years ↗

January 27, 2025

Via Benzinga

Earnings Scheduled For February 11, 2025 ↗

February 11, 2025

Via Benzinga

Healthcare And Biotech Playbook As Disruption Gathers Force ↗

February 10, 2025

The XBI was down 1.54% for the week, like off a cliff on Friday from a Wednesday high of $94.82.

Via Talk Markets

Topics ETFs Stocks / Equities

What To Expect When Biotech Giant Gilead Reports Q4 Earnings On Tuesday? ↗

February 10, 2025

Gilead reports Q4 earnings on Feb. 11. Analysts expect $1.70 EPS. The LEO Pharma deal could reduce 2025 EPS by up to $0.17.

Via Benzinga

Gilead Sciences (GILD) Q4 Earnings: What To Expect

February 10, 2025

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be announcing earnings results tomorrow afternoon. Here’s what to expect.

Via StockStory

3 Fabulous Dividend Stocks to Buy in February ↗

February 09, 2025

Via The Motley Fool

These 2 Dividend Stocks Are Absolute Bargains Right Now ↗

February 08, 2025

Via The Motley Fool

Top Analyst Reports For Uber, Comcast & Gilead ↗

February 07, 2025

Today's Research Daily features new research reports on 16 major stocks, including Uber Technologies, Inc., Comcast Corp, and Gilead Sciences, Inc., as well as a micro-cap stock Onfolio Holdings, Inc.

Via Talk Markets

Topics Stocks / Equities

3 Top AI-Powered Biotech Stocks to Buy in February ↗

February 06, 2025

Via The Motley Fool

Salesforce Names Board Member As Software Maker's New CFO And COO ↗

February 06, 2025

The Dow software giant named Robin Washington, as its new CFO and COO.

Via Investor's Business Daily

Topics Stocks

Can Biotech Stocks Survive The Precarious Macro? ↗

February 03, 2025

We were having a nice rally in January 2025 until the reality of tariffs hit on Friday which killed the momentum developing off the mid-January lows.

Via Talk Markets

Topics Stocks / Equities World Trade

Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts ↗

January 31, 2025

Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts could pose risks for companies with significant drug exposure.

Via Benzinga

Gilead Sciences to Release Fourth Quarter & Full Year 2024 Financial Results on Tuesday, February 11, 2025

January 28, 2025

From Gilead Sciences, Inc.

Via Business Wire

Demand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus

January 22, 2025

From FN Media Group LLC

Via GlobeNewswire

8 Health Care Stocks Whale Activity In Today's Session ↗

January 20, 2025

Via Benzinga

Goldman Sachs Thinks Mid-Cap Biotech MoonLake Could Soar Over 80%: Is Retail Watching Closely? ↗

January 17, 2025

Oppenheimer has included MoonLake among its top biotech picks for 2025, alongside Capricor, Gilead, Kymera, Praxis, and Prothena.

Via Stocktwits

Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases

January 11, 2025

From Gilead Sciences, Inc.

Via Business Wire

This McDonald's Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday ↗

January 10, 2025

Via Benzinga

Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference ↗

January 09, 2025

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.

Via Benzinga

Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus ↗

January 08, 2025

Galapagos NV plans to split into two entities by mid-2025, focusing on oncology cell therapy and innovative medicines, with €2.45 billion allocated to SpinCo's pipeline.

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.